Session 4 Flashcards

1
Q

What are monoclonal antibodies?

A

• Monoclonal antibodies are monovalent
antibodies which bind to the same
epitope and are produced from a single
B-lymphocyte clone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How are monoclonal antibodies made?

A
The generation of hybridomas involves
immunising a certain species against a
specific epitope on an antigen and
then harvesting the B-lymphocytes
from the spleen of the mouse
Monoclonal antibody
• The B-lymphocytes are then fused
with an immortal myeloma cell line
not containing any other
immunoglobulin-producing cells • The resulting  hybridoma cells are
then cultured in vitro so only the
hybridomas (i.e. the fusion between
the primary B-lymphocytes and
myeloma cells) survive
• Selected hybridomas are found
making a specific desired clonal
antibody
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Benefits of monoclonal antibodies

A

• Specific • Can be targeted against
almost any cell-surface
receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Types of monoclonal antibodies

A

Naked monoclonal antibodies
Conjugated monoclonal antibodies
Bispecific monoclonal antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Naked monoclonal antibodies

A

1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Conjugated monoclonal antibodies

A

2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Bispecific monoclonal antibodies

A

3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do monoclonal antibodies work

A

• Binding with cell surface receptors to either
• antibody-dependent cell-mediated cytotoxicity (ADCC) or • complement-dependent cytotoxicity (CDC)
activate or inhibit signalling within the cell • Binding to induce cell death • Binding with cell surface receptors to activate:
• Internalization (ie being taken in by the cell
through the membrane) for antibodies delivering
toxins into the cancer cell • Blocking inhibitory effects on T cells (checkpoints).
Thus activating T cells to help ‘kill’ the cancer cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Monoclonal antibodies in haematology

A
• Understanding what antigens
are present on cancer cells and
on normal tissue we could try to
develop specific targeted
treatments. • Cluster of differentiation (CD)
classification.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What type of cancer is lymphoma

A

• Lymphoma divided into B and T cell
neoplasms – clonal proliferations of lymphoid cells
• It typically causes enlargement of lymph
nodes • The spleen, bone marrow and other areas of
the body such as liver, skin, testes and bowel
(‘extra-nodal’) may also be involved • People with lymphoma often complain of
drenching night sweats, fevers and weight
loss .. But some have none of these
symptoms
The lymph node can be taken over by small clonal B lymphocytes which retain the follicular pattern Follicular lymphoma
These B cells express CD20
..or by larger clonal B lymphocytes which take over the node in a diffuse pattern. Diffuse large B cell lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Treatment strategies in lymphoma

A

• Chemotherapy • Radiotherapy • Monoclonal antibody therapy • Emerging new targeted therapy • Stem cell transplantation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why use mAbs in lymphoma

A

• Trials comparing chemo v R-
chemo
• Significantly improved complete
response rates (63 v 75%) • Significantly improved survival (at
10 years 28% v 44%) • Results highly significant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Side effects of monoclonal antibodies

A

• Some have no or mild symptoms eg mild fatigue • Many have a mild reaction to the 1st infusion and then
tolerate subsequent treatments well • A few people will have severe infusion related
reactions as their immune system reacts to the
presence of a ’foreign’ protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
How do patients feel when we use anti-CD20
monoclonal antibody (R) to treat B-cell lymphoma?
A

Q

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Managing infusion related reactions

A

• Patient education:
• Explain to the patient that even though they have received
premedication, they may still experience some side effects. • Explain that they should inform staff the moment of any change, so that
staff can take immediate action • Instruct patient to omit their anti-hypertension medication for 12 hours
prior to their infusion.
• Prevention with Pre-medication: steroid, anti-histamine,
paracetamol • Start at a slow infusion rate, slowly increase if tolerated • Drugs required to treat IRRs should be prescribed prior to
starting patients treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Wide use of monoclonal antibodies

A
  • Solid cancer
  • Trastuzumab – inhibition of HER-2 signalling • Bevacizumab – inhibition of VEG-F signalling • Nivolumumab – inhibition of CTLA-4 signalling
  • Autoimmune
  • Infliximab and Adalimumab – inhibition of TNF-alpha • Cardiology
  • Abciximab – inhibition of platelet glycoprotein IIb/IIIa • Endocrine
  • Denosumuab – inhibition of RANK ligand on osteoclasts